Second-line afatinib vs erlotinib for patients with squamous cell carcinoma (SCC) of the lung (LUX-Lung 8 [LL8]): analysis of tumour and serum biomarkers and long-term responders. (February 2017)

Record Type:
Journal Article
Title:
Second-line afatinib vs erlotinib for patients with squamous cell carcinoma (SCC) of the lung (LUX-Lung 8 [LL8]): analysis of tumour and serum biomarkers and long-term responders. (February 2017)
Main Title:
Second-line afatinib vs erlotinib for patients with squamous cell carcinoma (SCC) of the lung (LUX-Lung 8 [LL8]): analysis of tumour and serum biomarkers and long-term responders
Authors:
Gadgeel, S.M.
Soria, J.C.
Felip, E.
Cobo, M.
Lu, S.
Syrigos, K.
Lee, K.H.
Göker, E.
Georgoulias, V.
Li, W.
Guclu, S.
Isla, D.
Ardizzoni, A.
Dupuis, N.
Gibson, N.
Krämer, N.
Bühnemann, C.
Solca, F.
Ehrnrooth, E.
Goss, G.
Abstract:
Is Part Of:
European journal of cancer. Volume 72(2017)Supplement 1
Journal:
European journal of cancer
Issue:
Volume 72(2017)Supplement 1
Issue Display:
Volume 72, Issue 1 (2017)
Year:
2017
Volume:
72
Issue:
1
Issue Sort Value:
2017-0072-0001-0000
Page Start:
S185
Page End:
Publication Date:
2017-02
Subjects:
Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994
Journal URLs:
http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S0959-8049(17)30671-8 ↗
Languages:
English
ISSNs:
0959-8049
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
95.xml